Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Immunocore Holdings plc - American Depositary Shares
(NQ:
IMCR
)
33.16
+0.61 (+1.87%)
Streaming Delayed Price
Updated: 1:37 PM EST, Feb 2, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Immunocore Holdings plc - American Depositary Shares
< Previous
1
2
3
4
5
6
7
Next >
Immunocore to present at upcoming investor conferences
February 28, 2023
From
Immunocore Holdings Limited
Via
GlobeNewswire
Immunocore to Report Fourth Quarter and Full Year 2022 Earnings and Host Call on March 1, 2023
February 23, 2023
From
Immunocore Holdings Limited
Via
GlobeNewswire
Immunocore Reveals First Data From HIV Infection Candidate Study
↗
February 22, 2023
Via
Benzinga
Immunocore announces initial Phase 1 safety and pharmacodynamic activity data with first soluble TCR therapy for people living with HIV
February 22, 2023
From
Immunocore Holdings Limited
Via
GlobeNewswire
Analyst Ratings for Immunocore Hldgs
↗
November 30, 2022
Via
Benzinga
Where Immunocore Hldgs Stands With Analysts
↗
November 30, 2022
Via
Benzinga
7 Analysts Have This to Say About Immunocore Hldgs
↗
November 30, 2022
Via
Benzinga
Where Immunocore Hldgs Stands With Analysts
↗
November 10, 2022
Immunocore Hldgs (NASDAQ:IMCR) has observed the following analyst ratings within the last quarter:
Via
Benzinga
Biotech's Drug Pipeline Expands From Melanoma To Other Cancers
↗
February 13, 2023
Immunocore is the IBD Stock of the Day as the biotech company expands its pipeline. Earnings For IMCR stock are due in March.
Via
Investor's Business Daily
Is Biotech Immunocore About To Make A 25% Price Move?
February 07, 2023
Small-cap Immunocore has been a price leader within the biotech industry. Analysts have a "buy" rating on the stock and estimate that it will move 25% higher.
Via
MarketBeat
Topics
ETFs
Immunocore to present at upcoming investor conferences
February 01, 2023
From
Immunocore Holdings Limited
Via
GlobeNewswire
3 Pharma Stocks That Will Mint Millionaires
↗
January 30, 2023
These pharma stocks all have excellent risk-reward ratios and the companies have developed treatments that could easily become blockbusters.
Via
InvestorPlace
Immunocore announces strategic priorities including pipeline expansion for 2023 -2024
January 09, 2023
From
Immunocore Holdings Limited
Via
GlobeNewswire
What 6 Analyst Ratings Have To Say About Immunocore Hldgs
↗
October 13, 2022
Analysts have provided the following ratings for Immunocore Hldgs (NASDAQ:IMCR) within the last quarter:
Via
Benzinga
5 Analysts Have This to Say About Immunocore Hldgs
↗
September 14, 2022
Within the last quarter, Immunocore Hldgs (NASDAQ:IMCR) has observed the following analyst ratings:
Via
Benzinga
Immunocore to present at the 41st Annual J.P. Morgan Healthcare Conference
January 04, 2023
From
Immunocore Holdings Limited
Via
GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For December 16, 2022
↗
December 16, 2022
Via
Benzinga
Immunocore is awarded the Prix Galien France award for KIMMTRAK
December 15, 2022
From
Immunocore Holdings Limited
Via
GlobeNewswire
Immunocore presents ovarian cancer expansion data for ImmTAC® candidate IMC-C103C targeting MAGE-A4
December 08, 2022
From
Immunocore Holdings Limited
Via
GlobeNewswire
Immunocore and Gadeta Announce Agreement to Develop First Gamma Delta (γδ) TCR ImmTAC for Solid Tumors
December 02, 2022
From
Immunocore Holdings Limited
Via
GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For November 30, 2022
↗
November 30, 2022
Via
Benzinga
Immunocore to present at the 5th Annual Evercore ISI HealthCONx Conference
November 23, 2022
From
Immunocore Holdings Limited
Via
GlobeNewswire
Stocks That Hit 52-Week Lows On Monday
↗
November 21, 2022
During Monday's session, 50 stocks hit new 52-week highs.
Via
Benzinga
Procter & Gamble To Jump Over 16%? Here Are 5 Other Price Target Changes For Monday
↗
November 21, 2022
Via
Benzinga
After Bill Gates Dumps Billions In Berkshire To Buy Microsoft, His Quiet Biotech Portfolio Has Made A New Trade
↗
November 18, 2022
Bill Gates has two portfolios he makes trades from: the Bill & Melinda Gates Foundation and the Bill & Melinda Gates Foundation Trust.
Via
Benzinga
Immunocore presents new biomarker analysis for KIMMTRAK (tebentafusp-tebn) in metastatic uveal melanoma at the SITC 2022 Annual Meeting
November 11, 2022
From
Immunocore Holdings Limited
Via
GlobeNewswire
Is Mid-Cap Neurocrine Biosciences A Buy After Blowout Q3 Report?
November 11, 2022
Neurocrine Biosciences trended higher with the broad market Thursday, coming within a penny of Tuesday’s high of $125.99. It is forming a bullish channel.
Via
MarketBeat
Immunocore to present at the Jefferies London Healthcare Conference
November 10, 2022
From
Immunocore Holdings Limited
Via
GlobeNewswire
Immunocore Reports Third Quarter 2022 Financial Results and Provides Business Update
November 09, 2022
From
Immunocore Holdings Limited
Via
GlobeNewswire
Why Immunocore Shares Dipped 22%; Here Are 73 Biggest Movers From Friday
↗
September 12, 2022
Gainers Digital Media Solutions, Inc. (NYSE: DMS) shares climbed 71.9% to close at $2.20 on Friday after the company received a non-binding go-private proposal from Prism Data for $2.50 per share in...
Via
Benzinga
< Previous
1
2
3
4
5
6
7
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
